Sanofi's and Regeneron's Dupixent wins new stage of EU regulatory approval

Jan 26 (Reuters) - Gensight Biologics SA: * GENSIGHT BIOLOGICS REPORTS CASH POSITION AS OF DECEMBER 31, 2022, FY 2022 REVENUES AND PROVIDES BUSINESS UPDATE * GENSIGHT BIOLOGICS' CASH AND CASH

Jan 25 (Reuters) - Lysogene SA: * LYSOGENE: CONVERSION OF THE SAFEGUARD PROCEEDINGS INTO REORGANIZATION PROCEEDINGS * THIS REQUEST WAS EXAMINED AND APPROVED BY COMMERCIAL COURT OF NANTERRE AT HEARING

Jan 25 (Reuters) - Poxel SA: * POXEL RECEIVES ORPHAN DRUG DESIGNATION FROM THE EUROPEAN COMMISSION FOR PXL770 AND PXL065 FOR TREATMENT OF ADRENOLEUKODYSTROPHY * POXEL RECEIVES ORPHAN DRUG DESIGNATION

Jan 25 (Reuters) - Innate Pharma SA: * ANNOUNCES HART-SCOTT-RODINO CLEARANCE REGARDING EXPANSION OF ITS COLLABORATION WITH SANOFI ON NK CELL ENGAGERS * ANNOUNCED TODAY EXPIRATION OF WAITING PERIOD

Jan 24 (Reuters) - Medincell SA: * INITIATION OF THE PHASE 3 STUDY FOR THE SECOND LONG-ACTING INJECTABLE ANTIPSYCHOTIC USING MEDINCELL’S TECHNOLOGY (PROGRAM MDC-TJK) * PHASE 3 STUDY CONDUCTED IN U.S.

Jan 24 (Reuters) - Neovacs SA: * NEOVACS SA - MADE COMMITMENT ALONGSIDE PHARNEXT S.A. AS PART OF THE PROJECT TO TRANSFORM LATTER INTO SOCIETE EN COMMANDITE PAR ACTIONS (S.C.A.). Source text:

Jan 24 (Reuters) - Advicenne SA: * ADVICENNE REPORTS 2022 SALES UP 13% TO €3.7 MILLION * SIGNIFICANT GROWTH ACCELERATION IN H2 2022 * ANNOUNCES TODAY 2022 SALES OF €3.7 MILLION, UP 13% COMPARED TO THE

Jan 24 (Reuters) - Hyloris Pharmaceuticals SA: * HYLORIS ANNOUNCES COMMERCIAL PARTNERSHIP FOR MAXIGESIC® IV IN 9 EUROPEAN COUNTRIES * EXCLUSIVE LICENSING AND DISTRIBUTION AGREEMENT SIGNED WITH SALUS

Jan 23 (Reuters) - Eurobio Scientific SA: * 2022 TURNOVER OF EUR 152.5M * 15% CORE BUSINESS GROWTH AT EUR 93M * AT END OF 2022, EUROBIO SCIENTIFIC'S CASH POSITION WAS OVER EUR 85 MILLION, FOR A NET

Jan 20 (Reuters) - Cellectis Sa: * CELLECTIS AMENDS $20 MILLION CONVERTIBLE NOTE UNDER COLLABORATION AGREEMENT WITH ITS PARTNER CYTOVIA THERAPEUTICS * AMENDED AND RESTATED NOTE INCREASED APPLICABLE